Establishment of a Comprehensive Cardiac Amyloidosis Center in a Community Hospital Setting

Cardiac amyloidosis is a great masquerader that often results in misdiagnosis of this condition. Early clinical recognition is crucial for timely therapeutic interventions to improve survival in patients with cardiac amyloidosis. Currently, Food and Drug Administration (FDA)-approved medications wor...

Full description

Bibliographic Details

Published in:	Reviews in Cardiovascular Medicine
Main Authors:	Prabin Phuyal, Sabahat Bokhari
Format:	Article
Language:	English
Published:	IMR Press 2024-02-01
Subjects:	amyloidosis cardiac amyloidosis screening transthyretin
Online Access:	https://www.imrpress.com/journal/RCM/25/2/10.31083/j.rcm2502061